CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 78 enrolled
Drug / intervention
Regular care with additionally administration of questionnairesother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05482880
NCT05482880N/ACompleted
CompareCT.gov

Decisional Conflicts, Health-related Quality of Life and Satisfaction With Care in High-risk Cutaneous Squamous Cell Carcinoma in the Head-neck Region: Validated Questionnaires

Maastricht University Medical Center·observational·Posted Aug 1, 2022·Updated Jan 6, 2026

In Brief

An observational study evaluating Regular care with additionally administration of questionnaires for Cutaneous Squamous Cell Carcinoma and 9 related conditions. Completed, enrolled 78 participants across 2 sites.

Detailed Summary

Patient reported outcomes in patients with high-risk cutaneous squamous cell carcinoma in the head-neck region are an important part of the complex care for these patients. Health-related quality of life, decision conflicts in the choice of treatment and satisfaction with care have not yet been sufficiently studied in this patient group.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinomas, Squamous Cell Carcinoma of Head and Neck, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, Skin Cancer, High-Risk Cancer, Quality of Life, Satisfaction, Patient
CountriesNetherlands
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 1, 2022
Enrollment StartFeb 28, 2022
Primary CompletionNov 1, 2023
Study CompletionDec 1, 2024
TodayJul 1, 2026
Enrollment to primary: 1.7 yearsPosted 3.9 years ago

Interventions

Regular care with additionally administration of questionnairesother

Patients receiving regular care. In addition, validated questionnaires are administered at two measurement points: 1. after the multidisciplinary consultation, a baseline questionnaire\*, the decision conflict scale and the EQ-5D-5L questionnaire are administered by phone. 2. 1 month after completion of the treatment program (care pathway) the EQ-5D-5L, the BaSQoL and the EORTC IN-PATSAT32 questionnaires will be administered by phone. Completing the questionnaires takes about 30 minutes each time. \*Baseline questionnaire: gender, age, marital status, education level, World Health Organization (WHO) performance status, presence of informal care, stage and treatment of cSCC, history of skin cancer, presence of current other skin cancer, and average travel time to hospital.